Clinical Trial Update: Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating curcumin to improve inflammation and symptoms in patients with clonal cytopenia of undetermined significance, low-risk myelody…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clonal Cytopenia of Undetermined Significance
• Essential Thrombocythemia
• Myelodysplastic Syndromes
• Myelofibrosis
• Polycythemia Vera

Drugs mentioned

• Curcumin (curcumin)

Snippet

Sponsor: University of Southern California | Conditions: Clonal Cytopenia of Undetermined Significance, Essential Thrombocythemia | Phase 2 | Status: RECRUITING